Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 1,370 | 1,633 | 1,479 | 1,546 | 1,654 |
| Operating Income | -1,370 | -1,633 | -1,479 | -1,546 | -1,654 |
| Interest Expense | 4 | 4 | 2 | 1 | 3 |
| Other Income | 6 | 5 | 3 | 0 | 0 |
| Pre-tax Income | -1,368 | -1,631 | -1,478 | -1,546 | -1,657 |
| Net Income Continuous | -1,368 | -1,631 | -1,478 | -1,546 | -1,657 |
| Net Income | $-1,368 | $-1,631 | $-1,478 | $-1,546 | $-1,657 |
| EPS Basic Total Ops | -0.82 | -0.95 | -0.89 | -0.95 | -1.20 |
| EPS Basic Continuous Ops | -0.82 | -0.94 | -0.89 | -0.95 | -1.21 |
| EPS Diluted Total Ops | -0.82 | -0.95 | -0.89 | -0.95 | -1.20 |
| EPS Diluted Continuous Ops | -0.82 | -0.94 | -0.89 | -0.95 | -1.21 |
| EBITDA(a) | $-1,370 | $-1,633 | $-1,479 | $-1,546 | $-1,654 |